Biotechnology Editas Medicine Announces Positive Safety and Efficacy Data from the First Two Patients Treated in the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease December 6, 2022
Health Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray December 6, 2022
Health AbbVie to Showcase Migraine Portfolio and Pipeline During the 16th European Headache Federation Congress December 6, 2022
Biotechnology Ascendis Pharma to Initiate TransCon(TM) PTH U.S. Expanded Access Program for Adult Patients with Hypoparathyroidism December 5, 2022
Biotechnology Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Clinical Utility and Benefit of clonoSEQ® MRD Testing in Blood Cancer Patients at 2022 ASH Annual Meeting December 5, 2022
Health European Medicines Agency Accepts Tofersen Marketing Authorization Application to Treat Rare, Genetic Form of ALS December 5, 2022
Search
Health
